子宫动脉栓塞术治疗子宫肌瘤的临床效果分析  

Analysis of the clinical effect of uterine artery embolization in treating hysteromyoma

作　　者：付景丽[1] 黄燕[1] 杨鹰[1] 丁秋霞[1] 

机构地区：[1]第三军医大学附属新桥医院妇产科,重庆400037

出　　处：《西部医学》2017年第5期613-616,共4页Medical Journal of West China

基　　金：国家自然科学基金青年科学基金(81502690)

摘　　要：目的探讨子宫动脉栓塞术治疗子宫肌瘤的临床效果。方法选取2014年行子宫动脉栓塞术的80例子宫肌瘤患者,通过检测肌瘤内部及其周围血流信号、肌瘤体积大小变化、电话回访等资料,分析术后2年内临床症状及生命质量改善情况。结果子宫动脉栓塞术后3、6个月肌瘤内部及其周围血流信号明显减弱,术后3、6、12个月肌瘤的体积显著缩小(P<0.05),在术后2年肌瘤体积大小呈逐渐缩小、稳定趋势,术后2年内临床症状改善率为92.5%,生命质量有明显提高。结论双侧子宫动脉栓塞术治疗子宫肌瘤效果明显,保留了女性子宫生理功能,改善了患者生活质量,是一种安全、有效的微创治疗方法。Objective To explore clinical effect of uterine artery embolization （UAE） on treating of hysteromyo- ma. Methods The effect of UAE treatment on 80 patients with hysteromyoma were evaluated in 2014 year. The blood flow signal of hysteromyoma inside and around, volume change and visited information were used to observe the clinical effect and quality of life within 2 years after UAE operation. Results Blood flow signal significantly weakened at 3 and 6 months after UAE operation. The hysteromyoma volume was significantly reduced （P〈 0.05） at 3, 6 and 12 months after UAE operation. The hysteromyoma volume was gradually reduced, stable trend after 2 years. The clinical symptom improved rate was 92.5% within 2 years after UAE operated. Conclusion Clinical effect of uterine artery embolization is obvious on treating of hysteromyoma, which can retain the uterine physiological function and improve the life quality of patients. UAE is effective and safe in Uterine myoma therapy.

关 键 词：子宫动脉栓塞术 子宫肌瘤 临床疗效 

分 类 号：R737.33[医药卫生—肿瘤]